MYC and neoplasm: Although this panel was able to verify recombination of the targeted TSGs and identify rare somatic gene alterations (e.g., biallelic Pten deletions and Myc amplifications) in FFPE mouse tumor samples, it lacked the capability to comprehensively evaluate genome-wide fidelity for more complex alteration classes (31).